Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9932 |
High Similarity |
NPD1934 |
Approved |
0.973 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.9467 |
High Similarity |
NPD2801 |
Approved |
0.9419 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.9419 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.9419 |
High Similarity |
NPD6166 |
Phase 2 |
0.9252 |
High Similarity |
NPD1511 |
Approved |
0.9216 |
High Similarity |
NPD3882 |
Suspended |
0.9182 |
High Similarity |
NPD7074 |
Phase 3 |
0.9128 |
High Similarity |
NPD1512 |
Approved |
0.9119 |
High Similarity |
NPD7054 |
Approved |
0.9062 |
High Similarity |
NPD7472 |
Approved |
0.9057 |
High Similarity |
NPD3818 |
Discontinued |
0.9026 |
High Similarity |
NPD3817 |
Phase 2 |
0.8973 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8973 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8968 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8912 |
High Similarity |
NPD1549 |
Phase 2 |
0.8889 |
High Similarity |
NPD6797 |
Phase 2 |
0.8889 |
High Similarity |
NPD4380 |
Phase 2 |
0.8834 |
High Similarity |
NPD7251 |
Discontinued |
0.8808 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8797 |
High Similarity |
NPD5494 |
Approved |
0.879 |
High Similarity |
NPD7075 |
Discontinued |
0.879 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.878 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.878 |
High Similarity |
NPD7808 |
Phase 3 |
0.8718 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8649 |
High Similarity |
NPD2796 |
Approved |
0.8581 |
High Similarity |
NPD1510 |
Phase 2 |
0.8544 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8497 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8481 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8457 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8435 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8435 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8435 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8434 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8424 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8424 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8418 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8415 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8395 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8365 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8354 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8323 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8322 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8311 |
Intermediate Similarity |
NPD943 |
Approved |
0.8291 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8288 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8274 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8231 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8219 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8199 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8101 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8072 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.8061 |
Intermediate Similarity |
NPD1247 |
Approved |
0.8052 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8049 |
Intermediate Similarity |
NPD919 |
Approved |
0.8024 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8013 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7987 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7975 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7949 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7949 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7933 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7927 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7922 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7922 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7895 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7885 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7885 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7879 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7862 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7862 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7862 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7844 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7831 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7826 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7806 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7806 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7799 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7751 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7747 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7742 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.774 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7733 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7719 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7703 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7687 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7682 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7673 |
Intermediate Similarity |
NPD6190 |
Approved |
0.767 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7654 |
Intermediate Similarity |
NPD920 |
Approved |
0.7643 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7636 |
Intermediate Similarity |
NPD37 |
Approved |
0.7628 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7616 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7613 |
Intermediate Similarity |
NPD6651 |
Approved |
0.761 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7605 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7605 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7605 |
Intermediate Similarity |
NPD4966 |
Approved |
0.76 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7586 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7582 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7572 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7568 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7561 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7556 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7547 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7543 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7532 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7531 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7531 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7516 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7516 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7473 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7473 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7469 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7468 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7468 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7458 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7458 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7453 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7451 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7442 |
Intermediate Similarity |
NPD5242 |
Approved |
0.744 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7436 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7415 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7391 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7386 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7384 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7384 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7365 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7355 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7333 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7329 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7325 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7321 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.732 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7317 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7316 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7312 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7308 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.729 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7285 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7285 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7285 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7273 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7273 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7273 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7273 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7273 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7273 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7273 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7267 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7262 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7262 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7255 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7246 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.724 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7238 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7237 |
Intermediate Similarity |
NPD4749 |
Approved |
0.723 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7222 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7219 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7215 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7215 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7212 |
Intermediate Similarity |
NPD4662 |
Approved |
0.7212 |
Intermediate Similarity |
NPD4661 |
Approved |
0.72 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7193 |
Intermediate Similarity |
NPD5019 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7184 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7178 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7178 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7176 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7158 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7151 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7151 |
Intermediate Similarity |
NPD7038 |
Approved |
0.7151 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7151 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7151 |
Intermediate Similarity |
NPD7039 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD411 |
Approved |
0.7126 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7124 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7124 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7119
|
Intermediate Similarity |
NPD2163 |
Approved |